Antiviral Effect of Retro-2.1 against Herpes Simplex Virus Type 2 In Vitro

키워드

참고문헌 (52)

1. Whitley RJ, "Herpes simplex viruses", Clin. Infect. Diseases, 26, pp.541~553 (1998)[DOI]
2. Gupta R, "Genital herpes", Lancet, 370, pp.2127~2137 (2007)[DOI]
3. Celum CL, "The interaction between herpes simplex virus and human immunodeficiency virus", Herpes, 11(Suppl 1), pp.36A~45A (2004)
4. Wald A, "Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis", J. Infect. Dis., 185, pp.45~52 (2002)[DOI]
5. Lehtinen M, "Herpes simplex virus and risk of cervical cancer: a longitudinal, nested case-control study in the Nordic countries", Am. J. Epidemiol., 156, pp.687~692 (2002)[DOI]
6. Looker KJ, "An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection", Bull. World Health Organ, 86, pp.805~812 (2008)[DOI]
7. Johnston C, "HSV-2: in pursuit of a vaccine", J. Clin. Invest., 121, pp.4600~4609 (2011)[DOI]
8. Cassady KA, "New therapeutic approaches to the alphaherpesvirus infections", J. Antimicrob. Chemother., 39, pp.119~128 (1997)[DOI]
9. Morfin F, "Herpes simplex virus resistance to antiviral drugs", J. Clin. Virol., 26, pp.29~37 (2003)[DOI]
10. De SK, "H erpes simplex virus and varicella zoster virus: recent advances in therapy", Curr. Opin. Infect. Dis., 28, pp.589~595 (2015)
11. Stechmann B, "Inhibition of retrograde transport protects mice from lethal ricin challenge", Cell, 141, pp.231~242 (2010)[DOI]
12. Cai H, "Coats, tethers, Rabs, and SNAREs work together to mediate the intracellular destination of a transport vesicle", Dev. Cell, 12, pp.671~682 (2007)[DOI]
13. Carney DW, "Structural optimization of a retrograde trafficking inhibitor that protects cells from infections by human polyoma- and papillomaviruses", Bioorg. Med. Chem., 22, pp.4836~4847 (2014)[DOI]
14. Nelson CDS, "A retrograde trafficking inhibitor of ricin and Shiga-like toxins inhibits infection of cells by human and monkey polyomaviruses", Mbio, 4, pp.e00729~13 (2013)
15. Maginnis MS, "JC polyomavirus attachment, entry, and trafficking: unlocking the keys to a fatal infection", J. Neurovirol., 21, pp.601~613 (2015)[DOI]
16. Harrison K, "Vaccinia virus uses retromer-independent cellular retrograde transport pathways to facilitate the wrapping of intracellular mature virions during viral morphogenesis", J. Virol., 90, pp.10120~10132 (2016)[DOI]
17. Sivan G, "Retrograde transport from early endosomes to the trans-golgi network enables membrane wrapping and egress of vaccinia virus virions", J. Virol., 90, pp.8891~8905 (2016)[DOI]
18. Nonnenmacher ME, "Syntaxin 5-dependent retrograde transport to the trans-golgi network is required for adeno-associated virus transduction", J. Virol., 89, pp.1673~1687 (2015)[DOI]
19. Gupta N, "Inhibitors of retrograde trafficking active against ricin and Shiga toxins also protect cells from several viruses, Leishmania and Chlamydiales", Chem. Biol. Int., 267, pp.96~103 (2017)[DOI]
20. Canton J, "Targeting host syntaxin-5 preferentially blocks Leishmania parasitophorous vacuole development in infected cells and limits experimental Leishmania infections", Am. J. Pathol., 181, pp.1348~1355 (2012)[DOI]
21. Herweg J-A, "Proteomic analysis of the Simkaniacontaining vacuole: the central role of retrograde transport", Mol. Microbiol., 99, pp.151~171 (2016)[DOI]
22. Secher T, "Retrograde trafficking inhibitor of Shiga toxins reduces morbidity and mortality of mice infected with enterohemorrhagic Escherichia coli", Antimicrob. Agents Chemother., 59, pp.5010~5013 (2015)[DOI]
23. Dai W, "Antiviral effects of Retro-2cycl and Retro-2.1 against Enterovirus 71 in vitro and in vivo", Antiviral Res, 144, pp.311~321 (2017)[DOI]
24. Gupta N, "(S)-N-Methyldihydroquinazolinones are the active enantiomers of Retro-2 derived compounds against toxins", ACS Med. Chem. Lett., 5, pp.94~97 (2014)[DOI]
25. Mingo R M, "Replication of herpes simplex virus: egress of progeny virus at specialized cell membrane sites", J. Virol., 86, pp.7084~7097 (2012)[DOI]
26. Granzow H, "Egress of alphaherpesviruses: comparative ultrastructural study", J. Virol., 75, pp.3675~3684 (2001)[DOI]
27. Owen DJ, "Tegument assembly and secondary envelopment of alphaherpesviruses", Viruses, 7, pp.5084~5114 (2015)[DOI]
28. Bourinbaiar AS, "The activity of plantderived antiretroviral proteins MAP30 and GAP31 against herpes simplex virus in vitro", Biochem. Biophys. Res. Commun., 219, pp.923~929 (1996)[DOI]
29. Lund J, "Toll-like receptor 9-mediated recognition of herpes simplex virus-2 by plasmacytoid dendritic cells", J. Exp. Med., 198, pp.513~520 (2003)[DOI]
30. Crouch SP, "The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity", J. Immunol. Methods, 160, pp.81~88 (1993)[DOI]
31. Pauwels R, "Rapid and automated tetrazoliumbased colorimetric assay for the detection of anti-HIV compounds", J. Virol. Methods, 20, pp.309~321 (1988)[DOI]
32. Brown JC, "Herpesvirus capsid assembly: insights from structural analysis", Curr. Opin. Virol., 1, pp.142~149 (2011)[DOI]
33. Yao F, "Inhibition of herpes simplex virus type 2 (HSV-2) viral replication by the dominant negative mutant polypeptide of HSV-1 origin binding protein", Antiviral Res, 53, pp.127~133 (2002)[DOI]
34. Argenta DF, "Antiherpes evaluation of soybean isoflavonoids", Arch. Virol., 160, pp.2335~2342 (2015)[DOI]
35. Antoine TE, "Prophylactic, therapeutic and neutralizing effects of zinc oxide tetrapod structures against herpes simplex virus type-2 infection", Antiviral Res, 96, pp.363~375 (2012)[DOI]
36. Mues MB, "Dynasore disrupts trafficking of herpes simplex virus proteins", J. Virol., 89, pp.6673~6684 (2015)[DOI]
37. Boehmer PE, "Herpes simplex virus DNA replication", Annu. Rev. Biochem., 66, pp.347~384 (1997)[DOI]
38. Koyama AH, "Quantitative studies on the maturation process of herpes simplex virus type 1 in Vero cells", Virus Res, 10, pp.281~285 (1988)[DOI]
39. Harden EA, "Virucidal activity of polysaccharide extracts from four algal species against herpes simplex virus", Antiviral Res, 83, pp.282~289 (2009)[DOI]
40. Gong YH, "Evidence of dual sites of action of dendrimers: SPL-2999 inhibits both virus entry and late stages of herpes simplex virus replication", Antiviral Res, 55, pp.319~329 (2002)[DOI]
41. Kalu NN, "Nelfinavir inhibits maturation and export of herpes simplex virus 1", J. Virol., 88, pp.5455~5461 (2014)[DOI]
42. Brugha R, "Genital herpes infection: a review", Int. J. Epidemiol., 26, pp.698~709 (1997)[DOI]
43. Tsuchiya Y, "Antiviral activity of natural occurring flavonoids in vitro", Chem. Pharm. Bull., 33, pp.3881~3886 (1985)[DOI]
44. Akhtar J, "Viral entry mechanisms: cellular and viral mediators of herpes simplex virus entry", FEBS J, 276, pp.7228~7236 (2009)[DOI]
45. Agelidis AM, "Cell entry mechanisms of HSV: what we have learned in recent years", Future Virol, 10, pp.1145~1154 (2015)[DOI]
46. Hadigal S, "Exploiting herpes simplex virus entry for novel therapeutics", Viruses, 5, pp.1447~1465 (2013)[DOI]
47. Dan K, "The memory effect of heteropolyoxotungstate (PM-19) pretreatment on infection by herpes simplex virus at the penetration stage", Pharm. Res., 46, pp.357~362 (2002)[DOI]
48. Qiu M, "Poly (4-styrenesulfonic acid-co-maleic acid) is an entry inhibitor against both HIV-1 and HSV infections - potential as a dual functional microbicide", Antiviral Res., 96, pp.138~147 (2012)[DOI]
49. Schang LM, "Biophysical approaches to entry inhibitor antivirals with a broad spectrum of action", Future Virol, 9, pp.283~299 (2014)[DOI]
50. Noel R, "N-Methyldihydroquinazolinone derivatives of Retro-2 with enhanced efficacy against Shiga toxin", J. Med. Chem., 56, pp.3404~3413 (2013)[DOI]
51. Yu S, "Common pharmacophore of structurally distinct smallmolecule inhibitors of intracellular retrograde trafficking of ribosome inactivating proteins", Sci. Rep., 3, pp.3397~ (2013)[DOI]
52. Craig E, "Structurally optimized analogs of the retrograde trafficking inhibitor Retro-2cycl limit Leishmania infections", PLoS Negl. Trop. Dis., 11, pp.e0005556~ (2017)[DOI]

관련 논문AI추천